Oruka Therapeutics Inc. Common Stock vs Constellation Brands Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Constellation Brands Inc. Common Stock trades at $128.88 (market cap $21.50B). The key difference: Constellation Brands Inc. Common Stock is far larger — about 4.2× Oruka Therapeutics Inc. Common Stock's market cap, and Constellation Brands Inc. Common Stock pays a 3.24% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ORKA | STZ | |
|---|---|---|
Market Cap | $5.18B | $21.50B |
Volume | 490,798 | 2,104,680 |
Sector | Health | Consumer Staples |
52-Week High | $113.08 | $166.68 |
52-Week Low | $26.19 | $112.77 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $4.31B | $31.72B |
Dividend Yield | — | 3.24% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →